Singulair (montelukast) for asthma
Merck is introducing Singulair (montelukast) for asthma.
It's a new leukotriene antagonist...similar to Accolate (zafirlukast).
Some leukotrienes are potent bronchoconstrictors. In fact they used to be called "slow-reacting substance of anaphylaxis."
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote